COMPANY NEWS IN BRIEF
Unilever faces a dilemmaUnilever faces a dilemma after its 50-billion-pound (US$68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected.The bid for GSK's as
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 10:00.


Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie